SCHEMBL21476823

SCHEMBL21476823

c1ccc(-c2c3ccccc3c(-c3ccc(-c4nc(-c5ccc6ccccc6c5)nc(-c5cc6ccccc6o5)n4)cc3)c3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP1A2 P05177 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TP53 P04637 1/20 0.43
MAOB P27338 2/20 0.41
MAOA P21397 1/20 0.40
ALOX5 P09917 1/20 0.40
MAPT P10636 3/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ESR1 P03372 2/20 0.38
ESR2 Q92731 2/20 0.38
PLA2G2A P14555 1/20 0.38
PLA2G4A P47712 1/20 0.38
CYP19A1 P11511 1/20 0.38
PGR P06401 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21476588 0.96 MAOB (0.40) KDM4EALDH1A1HSD17B10CYP1A2SMN1; SMN2
SCHEMBL21476574 0.93 MAOB (0.46) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL21476470 0.92 MAOB (0.45) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL21476801 0.90 PLA2G2A (0.43) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL24226005 0.90 MAOB (0.44) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL21476799 0.90 MAOB (0.43) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL21476601 0.89 MAOB (0.43) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL21476865 0.89 MAOB (0.40) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL21476822 0.89 PLA2G2A (0.42) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1
SCHEMBL21476800 0.87 PLA2G2A (0.43) KDM4EALDH1A1HSD17B10SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2021-05-06 US disclosed
WO-2019198806-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2019-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210130336-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, MLX, LEF1 KDM4E 3458/4885ALDH1A1 1240/4885HSD17B10 4387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.